✦ LIBER ✦

Unusual cytologic manifestation of small-cell lung cancer in associated pleural effusion

✍ Scribed by Roxanne Smith; Gia-Khanh Nguyen

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 103 KB
Volume: 30
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.10403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromosome abnormalities in non-small ce

Chromosome abnormalities in non-small cell lung cancer pleural effusions: Cytogenetic indicators of disease subgroups

✍ Robyn Lukeis; David Ball; Louis Irving; O. Margaret Garson; Dr. Suzanne Hasthorp 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

A cytogenetic study of pleural effusions (PE) containing metastatic or invasive tumor cells from I I patients with non-small cell lung cancer (NSCLC) (3 squamous cell carcinomas [SQC] and 8 adenocarcinomas [ADC] including I giant cell variant) was performed t o identify non-random chromosome abnorma

Pre- and postresection thoracic washings

Pre- and postresection thoracic washings in non-small cell carcinoma of the lung: A cytological study of 44 patients without pleural effusion

✍ Danielle Vinette-Leduc; Hossein M. Yazdi; Azim Valji; Farid Shamji; Donna Maziak 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Pleural dissemination in non-small cell

Pleural dissemination in non-small cell lung cancer: Results of radiological evaluation and surgical treatment

✍ Eiichi Akaogi; Kiyofumi Mitsui; Masataka Onizuka; Shigemi Ishikawa; Hiroshi Tsuk 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

The aims of this study are to evaluate the diagnostic ability of chest computed tomography (CT) in the early detection of pleural disease and to analyze the results of surgical treatment for lung cancer with pleural dissemination. Twenty-three non-small cell lung cancer patients with pleural dissemi

Genomewide loss of heterozygosity and it

Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer

✍ Ruo-Chia Tseng; Jer-Wei Chang; Feng-Jen Hsien; Ya-Hui Chang; Chin-Fu Hsiao; Jung 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 462 KB 👁 1 views

## Abstract We extensively allelotyped a panel of 71 microdissected primary surgically resected non small cell lung cancer (NSCLC) tumors to identify chromosomal regions that are likely to contain tumor suppressor genes (TSGs) or associated with clinicopathologic and prognostic effects. Loss of het

Host immune gene polymorphisms were asso

Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese

✍ Juncheng Dai; Zhibin Hu; Jing Dong; Lin Xu; Shiyang Pan; Yue Jiang; Guangfu Jin; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 313 KB 👁 2 views

## Abstract Laboratory‐based studies showed that host immune genes could influence the prognosis of non‐small‐cell lung cancer (NSCLC). Therefore, genetic polymorphisms in host immune genes may serve as predictors for NSCLC clinical outcome. To test the hypothesis that functional single nucleotide

Induction of tubulin by docetaxel is ass

Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines

✍ Jinghua Tsai Chang; Gee-Chen Chang; Jiunn-Liang Ko; Hung-Ya Liao; Hsin-Ju Liu; C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 408 KB 👁 1 views

Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell